Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ended December 31, 2022 issued by Company's Registrar and Share Transfer Agent (RTA), i.e. M/s. Purva Sharegistry (India) Private Limited thereby confirming the compliances under the said regulation.
03-01-2023
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window

 Intimation of Trading Window Closure
29-12-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Appointment Of Compliance Officer

 Appointment of Mr. Ashok Somani, Director as Compliance Officer of the Company with effect from December 26, 2022.
26-12-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015

 Attached
26-12-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, December 26, 2022

 1. Considered and approved the resignation of Ms. Neha Vora as a Company Secretary and Compliance Officer of the Company with effect from December 15, 2022; 2. Approved the appointment of M/s Kavita Khatri & Associates, Company Secretaries as the Secretarial Auditor of the Company for the financial year 2022-23; and 3. Approved the appointment of Mr. Ashok Somani, Director as Compliance Officer of the Company with effect from December 26, 2022.
26-12-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for To Consider Other Business Matters On Monday, December 26, 2022

 CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/12/2022 ,inter alia, to consider and approve 1. To take on record Resignation of Ms. Neha Vora, Company Secretary and Compliance Officer of the Company; 2. Re-appointment of M/s Kavita Khatri & Associates, Company Secretaries as the Secretarial Auditor of the Company for the financial year 2022-23; 3. Any other matter with the permission of chair.
21-12-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 With reference to the captioned subject, this is to inform you that Ms. Neha Vora, an Associate Member of the Institute of Company Secretaries of India having membership no. A30747, has resigned from the position of the Company Secretary & Compliance Officer of the Company with effect from end of the office hours on December 15, 2022. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No.CIR/CFO/CMD/4/2015 dated 09th September 2015 are as per enclosed Annexure.
15-12-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
08-12-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper advertisement pertaining to financial results of the Company for the quarter and half year ended September 30, 2022.
21-10-2022
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
20-10-2022
Next Page
Close

Let's Open Free Demat Account